Development and characterization of a binge drinking model in mice for evaluation of the immunological effects of ethanol.

This study describes the development and characterization of a binge drinking model in which a single dose of ethanol (EtOH) is administered by gavage to B6C3F1 mice. Blood EtOH levels were monitored over time after administration of EtOH at doses of 3.0-7.0 g/kg. Peak levels were in the range of 0.2-0.5%, and clearance was complete within 2-12 hr. Substantial increases in blood corticosterone levels were noted. Behavioral changes in EtOH-treated mice aged 8 weeks ranged from no effect (3-4 g/kg) to severe ataxia (6-7 g/kg). In mice aged 16 weeks, a dosage of 7 g/kg caused less of the righting reflex in some animals and severe ataxia in most of the others. Clinical chemistry results did not indicate biologically important changes in general physiological/homeostatic systems in EtOH-treated mice, but there were indications of minor liver damage at the 7 g/kg dosage. Thus, administration of EtOH to B6C3F1 mice by gavage produces behavioral changes, changes in blood EtOH levels, and probably glucocorticoid levels representative of at least some human binge drinkers. The model was used to evaluate the effects of binge drinking on antibody responses, and the results indicate the model will be useful for such studies.

[1]  S. Pruett,et al.  Mechanisms of ethanol-induced suppression of a primary antibody response in a mouse model for binge drinking. , 1995, The Journal of pharmacology and experimental therapeutics.

[2]  S. Lightman,et al.  Hormones, peripherally activated prohormones and regulation of the Th1/Th2 balance. , 1994, Immunology today.

[3]  A. Munson,et al.  Comparison of ELISA and Plaque-Forming Cell Assays for Measuring the Humoral Immune Response to SRBC in Rats and Mice Treated with Benzo[a]pyrene or Cyclophosphamide , 1993 .

[4]  S. Pruett,et al.  Thymic atrophy caused by ethanol in a mouse model for binge drinking: involvement of endogenous glucocorticoids. , 1993, Toxicology and applied pharmacology.

[5]  G. Wand,et al.  The effects of mild ethanol intoxication on the hypothalamic-pituitary-adrenal axis in nonalcoholic men. , 1993, The Journal of clinical endocrinology and metabolism.

[6]  R. Room Measuring Alcohol Consumption in the United States , 1990 .

[7]  D. Finn,et al.  Temperature affects ethanol lethality in C57BL/6, 129, LS and SS mice , 1989, Pharmacology Biochemistry and Behavior.

[8]  J. Fenters,et al.  Development of a testing battery to assess chemical-induced immunotoxicity: National toxicology program's guidelines for immunotoxicity evaluation in mice , 1988 .

[9]  H. Ratajczak,et al.  Evaluation of host resistance and immunity in mice exposed to the carbamate pesticide aldicarb. , 1987, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[10]  R. Macgregor Alcohol and immune defense. , 1986, JAMA.

[11]  M. Tichy̌,et al.  QSAR Analysis and Data Extrapolation among Mammals in a Series of Aliphatic Alcohols , 1985 .

[12]  S. Ogston,et al.  Drivers, binge drinking, and gammaglutamyltranspeptidase. , 1982, British medical journal.

[13]  L. M. Atkins,et al.  Further evaluation of diethyldithiocarbamate as an antagonist of cisplatin toxicity. , 1982, Annals of clinical and laboratory science.

[14]  T. Cicero Neuroendocrinological effects of alcohol. , 1981, Annual review of medicine.

[15]  R. Schnell,et al.  Circadian rhythms in the biological response and disposition of ethanol in the mouse. , 1980, The Journal of pharmacology and experimental therapeutics.

[16]  R. Ritzmann,et al.  Corticosterone concentrations in mice during ethanol drinking and withdrawal , 1978, The Journal of pharmacy and pharmacology.

[17]  J. Mendelson,et al.  Adrenal function and alcoholism. I. Serum cortisol. , 1971, Psychosomatic medicine.

[18]  V. Marks,et al.  Plasma-hydrocortisone response to ethanol in chronic alcoholics. , 1969, Lancet.

[19]  F. W. Ellis Effect of ethanol on plasma corticosterone levels. , 1966, The Journal of pharmacology and experimental therapeutics.